Zhu BD et al / Acta Pharmacol Sin 2003 Sep; 24 (9): 907-912
-defensin-1 gene transcription
in human pulmonary gland epithelial cells1
ZHU Bing-Dong, FENG Yun, HUANG Ning, WU Qi, WANG Bo-Yao2
Research Unit of Infection & Immunity, West China Medical Center, Sichuan University, Chengdu 610041, China
1 Project supported by the National Natural Science Foundation of China (39970293, 39670305) and China Medical Board of New York Inc (98-681).
2 Correspondence to Prof WANG Bo-Yao. Phn 86-28-8550-1273. E-mail wangby@mail.sc.cninfo.net
Received 2002-07-02 Accepted 2003-03-05
KEY WORDS BCG vaccine; defensins; gene expression; respiratory mucosa; epithelial cells; Mycobacterium bovis
ABSTRACT
AIM: To examine the stimulatory effect of bacille Calmette-Guérin
(BCG) cell wall components on human
-defensin-1
(hBD-1) gene expression and analyze the response element in the 5'-flanking
region of the gene. METHODS: BCG cell wall proteins were fractionated
by Sephadex G-150 chromatography. Using reverse-transcription polymerase
chain reaction (RT-PCR) and Northern hybridization analysis, hBD-1 mRNA expression
was detected in a human pulmonary gland epithelial cell line SPC-A-1 cells.
Progressive deletions of 5'-flanking region of hBD-1 gene were produced by PCR
and ligated into promoterless chloramphenicol acetyltransferase (CAT) expression
plasmid to construct pCAT reporter plasmids. Reporter gene expression was determined
by ELISA. RESULTS: There was an obvious enhancement of hBD-1 mRNA expression
after stimulation with heat-inactivated BCG whole cells (50 mg/L), or the cell
wall components with a molecular weight of 18-30 kDa (3 mg/L) for 8 h. The upstream
sequence between -314 bp and +54 bp had the inducible activity by BCG, which
contained CCAAT/enhancer binding protein-
(C/EBP
), activator protein-1 (AP-1),
and CP2 cis element. CONCLUSION: BCG cell wall components (18-30
kDa) can stimulate hBD-1 mRNA expression in pulmonary gland epithelial cells.
The sequence (-314 /+54) containing C/EBP
,
AP-1, and CP2 binding sites in the upstream of hBD-1 is involved in this induction.
INTRODUCTION
Antimicrobial peptides are key components of innate immunity[1].
-Defensin (hBD-1) is one of subclasses
of antimicrobial peptides, and primarily expressed in various epithelial tissues
including skin, lung, and intestine[1,2]. In addition to their striking
microbicidal properties, mammalian defensins have chemotactic activity for immature
dendritic cells and memory T cells[3]. Human hBD-1 was first isolated
from human hemofi-ltrate obtained from patients with end-stage of renal disease[4].
It widely expresses in secreted glands and epithelial cells including pulmonary
submucosal gland epithelia[5,6]. The compromising of its activity
leads to susceptibility to the airway infection in cystic fibrosis, suggesting
the crucial role of hBD-1 in airway defense against infections[6].
It has been demonstrated that some
-defensins
such as human
-defensin-2 (hBD-2)
and bovine tracheal antimicrobial peptide (TAP) expression can be induced in
epithelial cells by LPS, IL-1
,
and TNF-
through Toll/NF-
B
pathway[7, 8]. However, someone thought that hBD-1 gene could not
response to inflammatory stimuli[9].
Mycobacterium tuberculosis including bacille Calmette-Guérin (BCG) has long been found to have powerful immunologic adjuvant activity, not only augment both cell-mediated and humoral immune response but also initiate innate defense mechanisms[10]. We therefore examined the stimulatory effect of BCG cell wall components on hBD-1 gene expression in human pulmonary gland epithelial cells and preliminarily analyzed the response element in the upstream region of the gene.
MATERIALS AND METHODS
Materials Human pulmonary gland epithelial SPC-A-1 cell line was obtained
from Shanghai Institute of Cell Biology and kept in our laboratory. BCG vaccine
Shanghai line (D2-PB302 line) was obtained from Chengdu Institute
of Biological Products. DNA polymerase, endonuclease, and one step RT-PCR kit
were purchased from Takara Company (Dalian, China). pCAT Basic and pSV-
-Galactosidase
control vector were from Promega Company (USA). DIG DNA labeling and detection
kit, Dorsper liposomal transfection reagent, CAT ELISA, and
-Gal
ELISA assay kit were purchased from Roche Company (Germany). BCA Protein Assay
Kit was from Pierce Company (USA). DNA sequencing was performed by Shanghai
Genecore Company.
Preparation of BCG cell wall protein fractions BCG were cultured in Sauton medium. Dry cells (300 mg) were suspended in 5 mL of phosphate-buffered saline (PBS, pH7.4) 0.02 mol/L containing phenyl-methylsulfonyl fluoride 4 mmol/L, Teween-80 0.05 %, and ethylene diaminetetraacetic acid 1 mmol/L, and sonicated with 20 kHz on ice for 2 min×5 times at 1-min interval each. The sonicate was centrifuged at 27 000×g for 30 min. The pellet was suspended in 2 mL of the phenylmethylsulfonyl fluoride-containing PBS buffer, layered over a discontinuous sucrose gradient composed of sucrose 27 %, 39 %, 49 % (w/w) and centrifuged at 100 000×g for 2 h. The particulate band at the interphase between 27 % and 39 % sucrose contained most of the cell walls of BCG[11]. Having been washed with PBS, the cell wall pellet was suspended in 2 mL of PBS 0.02 mol/L containing SDS 2 %. The proteins were extracted at room temperature for 2 h followed by centrifugation at 27 000×g for 30 min. The supernatant was subjected to Sephadex G-150 column (900 mm×16 mm), and proteins were eluted at a flow rate of 6 mL/h with PBS 0.02 mol/L containing SDS 0.5 %. Fractions were pooled based on the A280 readings detected by UV /VIS spectrometer (Lambda Bio40, Perkin Elmer, USA). SDS was removed by dialysis against superpured water at room temperature for 72 h. The relative molecular weight was determined by Tricine-SDS-PAGE (15 %). Protein concentration was measured by BCA Protein Assay Kit.
Cell culture and hBD-1 mRNA determination SPC-A-1 cells were
grown in RPMI-1640 medium at 37 ºC in 5 % CO2 air, and were
seeded into 35-mm plate one day before experiments at a concentration of 3×105
cells per well. After incubation with or without BCG for 8 h, Epithelial cells
were washed with PBS and total RNA was isolated using the TRIzol reagent. RNA
concentration was measured by UV Spectrometer. Total RNA (1 µg) served
as a template in a one-step reverse transcribed polymerase chain reaction (RT-PCR)
with an internal control of
-actin.
Four intron spanning specific primers were designed. Two of the primers for
hBD-1 amplification were as follows: R1, 5'-TTG TCT GAG ATG GCC TCA GGT GGT
AAC; R2, 5'-ATA CTT CAA AAG CAA TTT TCC TTT AT. The others for
-actin
were: A1, 5'-GCG GGA AAT CGT GCG TGA CAT T; A2, 5'-GAT GGA GTT GAA GGT AGT TTC
GTG. The thermocycling program of the one step RT-PCR consisted of a reverse
transcription at 50 ºC for 30 min, an initial denaturation at 94 ºC
for 2 min, 25 to 35 cycles (denaturation at 94 ºC for 30 s, annealing at
58 ºC for 30 s, and elongation at 68 ºC for 45 s), and a final 7-min
elongation at 68 ºC. PCR products were subjected to electrophoresis on
an 1.5 % agarose gel. For Northern hybridization analysis, total RNA (about
4 µg) were separated by electrophoresis on agarose gel containing formaldehyde,
then transferred to positively charged nylon membranes. The hBD-1 and
-actin
RT-PCR products were used as probes. According to the instruction of DIG DNA
labeling and detection kit, probe labeling and detection were performed.
Construction of hBD-1 reporter plasmids Based on a previously published sequence of the hBD-1 gene[12] and chromosome 8 working sequence (GenBank number: AF298854), progressive deletions of promoter sequence were isolated by PCR amplification. A common antisense primer, 5'-GTG TCT AGA TTT GGA GGC TGA GCT GAC AG , corresponding to the sequence between positions +54 and +38 relative to transcription start site and containing a XbaI restriction enzyme site (underlined) was used in the PCR reaction. The oligonucleotides used as sense primers each contained a HindIII restriction enzyme site (underlined) and were as follows: -2161 bp, 5'-CAG AAG CTT TCG GCT CAC TAC AAC CAA TG; -575 bp, 5'-GAC AAG CTT GAG GAG TGC CCT TTG GAA AC; -484 bp, 5'-CAG AAG CTT GAT GAG AAG GTA GCC TTG GC; and -314 bp, 5'-GTG AAG CTT CCT CCA TGT GAT CCA GAA GG. Typically, the PCR reaction thermocycl-ing program consisted of initial denaturation at 94 ºC for 3 min, followed by 6 cycles of 20-s denaturation at 94 ºC, 20-s annealing at 65 ºC, and 36-s elongation at 72 ºC, then followed by 26 cycles of 20-s denaturation at 94 ºC, 20-s annealing at 58 ºC, and 36-s elongation at 72 ºC. A final 8-min elongation at 72 ºC was followed. For amplication of the long sequence (-2161/+54), the denaturation and annealing time were prolonged to 30 s, elongation time was extended to 2 min in every cycle. The PCR fragments were digested with HindIII and XbaI, and ligated into the HindIII and XbaI sites of a promoterless pCAT Basic Vector. One deletion con-struct, pCAT -69 plasmid, was generated from pCAT-575 plasmid by HindIII and SalI digestion. Each construct was verified by sequencing.
Transfection and CAT assay SPC-A-1 cells were plated at 3×105
cells per 35-mm dish one day before transfection. When the cells were
60 % to 80 % confluent, growth media were replaced with serum-free culture medium.
By using Dosper Liposomal transfection reagent, the hBD-1 CAT reporter constructs
(2.0 mg per well) were introduced into SPC-A-1 cells co-transfected with internal
control pSV-
-galactosidase control
plasmid (0.3 µg per well). After incubation for 6 h the transfection media
were replaced with 2 mL of fresh growth medium and the cells were further incubated
with or without BCG cell wall components for 39 h. CAT and
-Gal
concentrations of the cell lysate were assayed by ELISA following the manu-facturer's
instruction.
-Gal concentration
values were used to normalize CAT activity between different transfections for
transfection efficiency.
Statistics Data were presented as mean±SD and compared with paired t-test.
RESULTS
BCG enhanced hBD-1 mRNA expression in SPC-A-1 cells Whole BCG cells were inactivated by boiling for 10 min and used to stimulate SPC-A-1 cells. RT-PCR detection indicated that an obvious enhancement of hBD-1 mRNA expression in SPC-A-1 cells was observed after incubation with 50 mg/L of whole BCG cells for 8 h (Fig 1A). Different PCR cycles and Northern hybridization analysis confirmed this finding (Fig 1B). BCG-induced enhancement of hBD-1 mRNA expression was time- and dose-dependent[13].
Fig 1. BCG-induced enhancement of hBD-1 mRNA expression in human pulmonary
gland epithelial cells. SPC-A-1 cells were incubated with or without BCG whole
cell (50 mg/L) for 8 h.
-Actin
served as an internal control. (A) RT-PCR detection. Total RNA (1 µg) was
applied for one step RT-PCR with different cycles. (B) Northern hybridization.
The total RNA (4 µg) was used for Northern hybridization. Lane 1: unstimulated;
Lane 2: stimulated with BCG; Lane M: marker. This was the representative of
3 independent experiments.
In search for the effective components of BCG, the cell wall proteins were isolated and fractionated by Sephadex G-150 chromatography. Two fractions of the cell wall proteins were obtained (Fig 2A). The second fraction with a range of molecular weight from 18 kDa to 30 kDa seemed to be more effective in the stimulation of hBD-1 mRNA expression detected by RT-PCR (Fig 2B).
Fig 2. BCG cell wall components induced hBD-1 expression in SPC-A-1 cells.
(A) Tricine-SDS-PAGE (15 %) of BCG cell wall protein fractions isolated by Sephadex
G-150. Lane M: protein marker; Lane W: whole BCG cell wall proteins; Lane 1:
fraction 1; Lane 2: fraction 2. (B) RT-PCR detection of hBD-1 mRNA expression.
SPC-A-1 cells were incubated with or without BCG for 8 h. Total RNA (1 µg)
of which was applied for one step RT-PCR (30 cycles) with
-actin
as an internal control. Lane M: marker; Lane N: nonstimulation; Lane W: whole
cell stimulation (50 mg/L); Lane 2: the fraction 2 stimulation (3 mg/L). This
was the representative of three independent experiments. (C) CAT activity determination
of hBD-1 reporter plasmid pCAT _575. pCAT _575 construction was shown in Fig
3A. SPC-A-1 cells were co-transfected with pCAT -575 (2.0 µg per well)
and pSV-
-galactosidase control
plasmid (0.3 µg per well), then incubated with or without BCG cell wall
protein fractions (3 mg/L) for 39 h. CAT and
-Gal
concentrations of the cell lysate were determined by ELISA. [CAT]/[
-Gal]
represents CAT activity. n=3 independent experiments. Mean±SD.
aP>0.05, bP<0.05 vs
unstimulated.
Analysis of BCG response element in the 5'-flanking region of hBD-1 gene Firstly we constructed pCAT -575 reporter plasmid. Its transfection experiment showed that the -575/+54 sequence of hBD-1 gene could drive CAT gene transcription and expression in SPC-A-1 cells after incubation with the second fraction of BCG cell wall proteins (Fig 2C). The -2161/+54 sequence had almost the same transcription activity. The BCG cell wall proteins inducibility remained in all constructs pruned to -69 bp (Fig 3B). Using MatInd and MatInspector analysis programs[14], the -575 bp/+54 bp sequence of the hBD-1 gene was searched for potential transcription factor sites in a Transfac tran scription factor database (http://tansfac.gbf.de/TRANSFAC). Multiple high homologous cis elements were found among the sequence from _575 bp to the first extron (Tab 1).
Fig 3. Analysis of BCG response sequence in the 5'-flanking region of
hBD-1 gene. (A) Diagram of hBD-1 reporter gene construction. Progressive deletions
of 5'-flanking region in hBD-1 gene were isolated by PCR and ligated into pCAT
Basic vector to construct a series of hBD-1 CAT reporter plasmids. pCAT _69
was generated from pCAT _575 by digestion with SalI. (B) CAT activity
determination of the reporter plasmids. SPC-A-1 cells were co-transfected with
the hBD-1 CAT constructs (2.0 µg per well) and pSV-
-galactosidase
control plasmid (0.3 µg per well), then incubated with or without the BCG
cell wall components (18-30 kDa, 3 mg/L) for 39 h. CAT and
-Gal
concentrations of the cell lysate were determined by ELISA. [CAT]/[
-Gal]
represents CAT activity. n=3 independent experiments. Mean±SD. bP<0.05,
cP<0.01 vs unstimulated construct.
Tab 1. Consensus match analysis for potential transcription factor binding sites in hBD-1 gene 5'-flanking region.
Note: 1, Matrix positions correspond to sense strand numbering relative
to transcription start site. 2, Capital letters within the sequence indicate
the core string. 3, NFAT: nuclear factor of activated T-cells; IRF2: interferon
regulatory factor 2; MZF: myeloid zinc finger protein; NF-1: nuclear factor-1;
AP-1: activator protein-1; C/EBP
:
CCAAT/enhancer binding protein-
.
DISCUSSION
Our environment is contaminated by an enormous number and variety of microorganisms
and we have developed many host defenses to contend with the invaders. The epithelial
lining of our skin, gastrointestinal and genitourinary tracts, and tracheobronchial
tree produces a number of antimicrobial peptides, and our phagocytic neutrophils
rapidly ingest and enzymatically degrade invading organisms, as well as produce
peptides and enzymes with antimicrobial activities. Some of these antimicrobial
molecules also appear to alert host cells involved in both innate host defense
and acquired immune response[15]. hBD-1 is the most important antimicrobial
peptide in human epithelial defense against infection[6]. Study of
hBD-1 gene expression regulation would not only contribute to understanding
the mucosal defense mechanisms, but also have a potential application in prevention
and treatment of respiratory, genitourinary, and gastrointestinal infections.
The most significant progress in the regulation of antimicrobial peptide gene
expression is the finding of inducible epithelial antimicrobial peptides such
as TAP and hBD-2 by LPS, IL-1
,
and TNF-
via Toll/NF-
B
pathway[7,8]. Our study and other's[16,17] provide evidence
that hBD-1 gene dose response to some bacterial factors or inflammatory stimuli
although someone thought that the expression of hBD-1 did not appear to be affected
by bacterial factors and proinflammatory mediators[9, 17] .
In our study, several detections such as RT-PCR, Northern hybridization, and reporter gene experiments indicated that BCG, especially its cell wall components (18-30 kDa) enhanced hBD-1 gene expression at transcription level in human pulmonary gland epithelial cells.
Unlike TAP and hBD-2, there is no transcription factor NF-
B
binding site in the upstream region of hBD-1 gene[12]. We therefore
preliminarily analyzed its upstream sequence responsible for the induction of
hBD-1 gene expression by BCG. A series of progressive deletion sequences in
the upstream region of hBD-1 gene were produced by PCR and their CAT reporter
plasmids were constructed. The transfection experiments indicated that the BCG
cell wall protein inducibility remained in all constructs from -2161 to -69
bp, suggesting that -69/+54 sequence be essential for the induction of hBD-1
gene expression by BCG cell wall proteins. Consensus match analysis revealed
that the region from -63 to -50 bp was homologous to CCAAT/enhancer binding
protein-
(C/EBP
)
motif. C/EBP
(alternative name,
NF-IL6) is a member of C/EBP family[18], which is involved in regulation
of cellular differentiation, inflammation, and immunity. Accumulating data suggest
that C/EBP
may play an important
role in the induction of inflammatory response. C/EBP
binding motif has been identified in the functional regulatory region of various
genes including acute phase proteins, IL-6, IL-8, IL-12, nitric oxide synthase,
and TAP[8,18,19].
Because the fold-increase in the transcripition activity of -69 construct was lower than that of -314 and other constructs, multiple transcription factors might cooperate in BCG-mediated up-regulation of hBD-1 gene expression in human gland epithelial cells. The -314 sequence also contained potential transcription factor activator protein-1 (AP-1) and CP2 sites. AP-1 is another important transcription factor to regulate inflammation reaction[20,21]. For example, it dominantly participates in the regulation of inducible expression of granulysin, an antimicrobial protein, after stimulation with Acholeplasma laidlawii[21]. CP2 is found to regulate the expression of IL-4[22].
In conclusion, BCG cell wall components (18-30 kDa) can up-regulate hBD-1 gene
expression at transcription level in human pulmonary gland epithelial cells.
The sequence containing C/EBP
,
AP-1, and CP2 sites in the upstream of hBD-1 gene is involved in this induction.
REFERENCES
-defensin from human
plasma. FEBS Lett 1995; 368: 331-5.
-defensin-1
is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis.
Cell 1997; 88: 553-60.
-defensin 2 in
response to bacterial lipoprotein. Eur J Immunol 2001; 31: 3131-7.
-defensin gene
expression in tracheal epithelial cells. Infect Immun 2000; 68: 113-9.
-Defensins:
endogenous antibiotics of the innate host defense response. Clin Immunol Immunopathol
1998; 88: 221-5.
-defensin-1
and
-defensins are encoded by
adjacent genes: two peptide families with differing disulfide topology share
a common ancestry. Genomics 1997; 43: 316-20.
-defensin-1 gene expression.
Chin J Microbiol Immunol 2001; 21: 400-3.
defensin-1 and
-2 expression in human pilosebaceous units: upregulation in acne vulgaris
lesions. J Invest Dermatol 2001; 117: 1120-5.
-defensin-1
promotes differentiation of keratinocytes. J Mol Med 2001; 79: 275-82.